MedPath
HSA Approval

REFRAT TABLET 500mg

SIN13695P

REFRAT TABLET 500mg

REFRAT TABLET 500mg

August 20, 2009

STRIDES PHARMA GLOBAL PTE. LIMITED

STRIDES PHARMA GLOBAL PTE. LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSTRIDES PHARMA GLOBAL PTE. LIMITED
Licence HolderSTRIDES PHARMA GLOBAL PTE. LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

L04AA06

mycophenolic acid

Manufacturer Information

STRIDES PHARMA GLOBAL PTE. LIMITED

Strides Pharma Science Limited

Active Ingredients

Mycophenolate Mofetil

500 mg

FN-1501

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

REFRAT TABLET 500mg - HSA Approval | MedPath